Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2501-2510 of 10665

Edit search filters
  1. Density MATTERS [Molecular Breast Imaging (MBI) And Tomosynthesis To Eliminate the Reservoir]

    Rochester, MN, La Crosse, WI

  2. A Study of the Use of Virtual Reality Equipment to Decrease Pre-Surgical Anxiety for Open Chest Heart Surgery Patients

    Rochester, MN

  3. EEG Cap for Identification of Non-Convulsive Status Epilepticus

    Jacksonville, FL

  4. Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

    Rochester, MN

  5. Techquity by FAITH!

    Minneapolis, MN, Rochester, MN

  6. A Study to Evaluate Anterior Vertebral Body Tethering (AVBT) Zimmer Biomet Tether System or Dynesys System to Treat Pediatric Scoliosis

    Rochester, MN, Minneapolis, MN, Eau Claire, WI, La Crosse, WI

  7. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy

    Rochester, MN

  8. Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

    Rochester, MN

  9. A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

    Scottsdale/Phoenix, AZ

  10. A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

.

Mayo Clinic Footer